Healthcare Dollar Volume Exploded in January

Dollar volume for healthcare deals announced in January was ridiculous, topping $90 billion. We don’t see figures like that in most quarters. The outsized total results from a single deal, of course. Bristol-Myers Squibb’s (NYSE: BMY) $74 billion acquisition of Celgene Corp. (NASDAQ: CELG) made up 81% of the month’s total. Suffice it to say […]

Healthcare Deal Volume Got a Jump Start in January

January was a fairly busy month for healthcare M&A. Preliminary data shows 133 deals reported, nearly equal to December’s 136. The momentum coming out of the fourth quarter spilled into the new year and even without a big boost in deal announcements from the J.P. Morgan Healthcare Conference, consolidation in the industry seems to be […]

Healthscope Changes Hands Again

Healthscope Ltd. (ASX: HSO), Australia’s second largest private hospital chain, is being sold once again, this time for $4.14 billion, or 1.8x revenue. The Melbourne, Victoria-based company owns 43 hospitals across all states in Australia and is the largest pathology services provider in New Zealand, with 24 laboratories. Three buyers are involved, two of them real […]

Thermo Fisher Sells Its Anatomical Pathology Business

Shortly before it reported fourth quarter and full-year earnings results, Thermo Fisher Scientific (NYSE: TMO) announced the sale of its anatomical pathology (AP) business for $1.14 billion. The buyer, Tokyo-based PHC Holdings Corporation, is a global healthcare company developing and manufacturing medical equipment and products across diabetes care, diagnostics, life sciences and healthcare information technology. […]

Home Health & Hospice Deals Kick Off 2019

The Home Health & Hospice sector is predicted to see a great deal more mergers and acquisitions in 2019 than it has in recent years. Bullish industry watchers cite the growing momentum behind value-based health care delivered in lower-cost settings as just one tailwind that is expected to boost the sector. This sector closed out […]

TA Associates Climbs on the Autism Bandwagon

Autism disorders are big business these days, as private equity firms flock to the subsector. More than 40 deals targeting all manner of autism services have been announced since the beginning of 2014. Of those, 17 were direct investments by firms such as Frazier Healthcare Partners (August 2018) and Pharos Capital Group (November 2018) and […]